Cancer Research Collaboration intends to develop a biobank, which will house biospecimens and clinical data. These will be made available to researchers working in various areas of molecular medicine and pharmaceutical research.
What is a biobank and why is it important?
A biobank is essentially a warehouse used to store biospecimens submitted by patients, such as tumor tissue and blood samples. These biospecimens are stored along with information regarding demographics and clinical data. Biobanks are essential to enabling research in the field of molecular medicine, which can lead to the development of new targeted therapies and interventions that can advance personalized medicine and improve outcomes for cancer patients.
How can researchers benefit from a biobank?
In recent years, the medical community has identified new ways of identifying genes and their functions. This has helped advance our understanding of the role they play in the development of cancers and other health conditions.
With vast amounts of information synthesized from patient records and clinical trials, researchers can continue to identify cancer sub-types. This can lead to the development of new strategies for diagnosing and treating cancers in more effective, targeted ways.
Biospecimens and clinical data available to researchers in the Cancer Research Collaboration biobank will aid efforts to:
- Find new ways to deliver drugs and agents to specific cells.
- Learn how different diseases and cancer subtypes progress.
- Determine which patients are likely to respond to specific therapies and interventions.
- Develop screening tests to detect biomarkers associated with certain stages and subtypes of cancer.
If you have any questions regarding this future project or if you want to donate to development of our biobank, please contact us.